Table 4 Anti-trastuzumab Ab levels developed in patien’s serum samples after trastuzumab treatment course
From: Trastuzumab immunogenicity development in patients’ sera and in laboratory animals
Sample code | Titer | *Elapsed time (months) | |
|---|---|---|---|
Value | ±SD | ||
T3–97 | ND | 4 | |
T3–98 | ND | 11 | |
T3–99 | 103.63 | 5.58 | 22 |
T3–100 | 7.13 | 0.1395 | 9 |
T3–101 | ND | 7 | |